Preparation and Characterization of PEGylated C18 Fatty Acids/Anti-SNAP25 Antibody-Targeted Liposomes
-
Published:2019-07-12
Issue:2
Volume:13
Page:129-139
-
ISSN:2212-7968
-
Container-title:Current Chemical Biology
-
language:en
-
Short-container-title:CCB
Author:
Gew Lai Ti1, Eh Suk Vicit Rizal1, Misran Misni1
Affiliation:
1. Department of Chemistry, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia
Abstract
Background:
Unsaturated C18 fatty acids, such as oleic acid (L1), linoleic acid
(L2), and linolenic acid (L3), are a good choice of lipids to prepare liposomes. They are
inexpensive, biocompatible, nontoxic, and readily available compared with phospholipids.
Moreover, cis-double bonds of unsaturated fatty acids prevent the packing of molecules
which increases membrane fluidity in liposomes making them a good choice of starting
materials to prepare liposomes.
Objective:
Unsaturated C18 fatty acid liposomes, as well as their PEGylated and non-
PEGylated antibody-targeted liposomes, were prepared and characterized.
Methods:
The particle size and zeta potential of the prepared liposomes (1 mM, pH = 7.4)
for 28 and 14 days, respectively, were monitored and characterized. Membrane-bound
antibodies Anti-SNAP25 (AS25) and DOPE PEG2000 (DP) were conjugated to pure C18
fatty acid liposomes to achieve stable fatty acid formulations.
Results:
The mean particle sizes of pure L1, L2, and L3 liposome solutions were 125, 129,
and 122 nm respectively, while their polydispersity index values were 0.28, 0.21, and 0.40
respectively. A large negative zeta potential value of 45 mV was observed due to anionic
carboxylate head-group of pure liposomes. The incorporation of AS25 into L1/DP, L2/DP,
and L3/DP liposome solutions stabilized their mean particle size and zeta potential
measurements over 28 and 14 days, respectively.
Conclusion:
L1/DP/AS25 was found to be the most stable PEGylated antibody-targeted
liposome system because its particle size remained between 90 and 125 nm in 28 days.
Transmission electron microscopy observations also supported the incorporation of AS25
and DP on the membrane surface as predicted.
Funder
University of Malaya Research Grant Programme SUS by University of Malaya, Malaysia
Publisher
Bentham Science Publishers Ltd.
Reference35 articles.
1. Weiss A, Neuberg P, Philippot S, Erbacher P, Weill CO. Biotechnol Bioeng, Intracellular peptide delivery using amphiphilic lipid‐based formulations.,, 2011, 108,, 2477-2487, 2. Martins S, Sarmento B, Ferreira DC, Souto EB. Int J Nanomedicine, Lipid-based colloidal carriers for peptide and protein delivery–liposomes versus lipid nanoparticles.,, 2007, 2,, 595-, 3. Pisal DS, Kosloski MP, Balu‐Iyer SV. J Pharm Sci, Delivery of therapeutic proteins.,, 2010, 99,, 2557-2575, 4. Rawat M, Singh D, Saraf S, Saraf S. J Pharm Soc Jap, Lipid carriers: A
versatile delivery vehicle for proteins and peptides.,Yakugaku zasshi-, 2008, 128,, 269-80, 5. Chang HI, Yeh MK. Int J Nanomedicine, Clinical development of liposome-based drugs: Formulation, characterization, and therapeutic efficacy.,, 2012, 7,, 49-,
|
|